{
    "Trade/Device Name(s)": [
        "Xpert\u00ae C. difficile/Epi",
        "C. difficile/Epi Assay",
        "C. diff/Epi Assay",
        "Clostridium difficile identification and differentiation system"
    ],
    "Submitter Information": "Cepheid",
    "510(k) Number": "K110203",
    "Predicate Device Reference 510(k) Number(s)": [
        "K091109",
        "K081920"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "OMN"
    ],
    "Summary Letter Date": "April 7, 2011",
    "Summary Letter Received Date": "January 24, 2011",
    "Submission Date": "January 21, 2011",
    "Regulation Number(s)": [
        "21CFR866.2660"
    ],
    "Regulation Name(s)": [
        "Microorganism differentiation and identification device"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Clostridium difficile toxin B gene (tcdB)",
        "binary toxin gene (CDT)",
        "tcdC\u0394117 deletion"
    ],
    "Specimen Type(s)": [
        "Unformed (liquid or soft) stool"
    ],
    "Specimen Container(s)": [
        "Tube containing elution reagent",
        "Disposable fluidic cartridge",
        "Swab"
    ],
    "Instrument(s)/Platform(s)": [
        "Cepheid GeneXpert Dx System"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Qualitative nucleic acid amplification"
    ],
    "Methodologies": [
        "Multiplex polymerase chain reaction (PCR)",
        "Automated sample preparation"
    ],
    "Submission Type(s)": [
        "Assay",
        "System",
        "Cartridge",
        "Reagent",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for Cepheid Xpert C. difficile/Epi qualitative PCR assay for rapid detection and differentiation of toxigenic Clostridium difficile from stool specimens.",
    "Indications for Use Summary": "Qualitative in vitro diagnostic test for rapid detection of toxin B gene sequences and presumptive identification of 027/NAP1/BI strains of toxigenic Clostridium difficile from unformed stool specimens of patients suspected of having C. difficile infection; results intended as an aid in diagnosis and for epidemiological purposes, not treatment guidance.",
    "fda_folder": "Microbiology"
}